← Open Payments lookup

YIM CHAN: Open Payments

NPI 1659458289 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$908 in 12 payments from 5 companies in 2025. Trend: 2023 $2,584 · 2024 $1,260 · 2025 $908

Food & beverage: $908
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.5$372
Axsome Therapeutics, Inc.2$258
Otsuka America Pharmaceutical, Inc.2$124
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$123
E.R. Squibb & Sons, L.L.C.2$31

Products named: Auvelity, UZEDY, AUSTEDO XR, CAPLYTA, REXULTI, COBENFY, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.